MRK – Merck & Co Stock Premarket Price
MRK Premarket Chart
About Merck & Co Inc
Merck & Co. Inc. is a renowned multinational pharmaceutical company. Founded in 1891, Merck is recognized for its contributions to the healthcare sector, including the development of prescription drugs and vaccines. The company’s products address a wide range of medical conditions and health challenges. Merck’s commitment to medical research and innovation has led to significant advancements in the field of pharmaceuticals. As a leader in the healthcare industry, Merck continues to play a crucial role in improving global health and well-being.
Latest News
- Wells Fargo shares jump after earnings beat, strong 2025 guidance
- Mark Wiedman, a top BlackRock exec thought to be Fink's successor, is leaving the company
- Stocks making the biggest moves midday: Eli Lilly, Applied Digital, Boeing and more
- Health care jobs are in demand in 2025 — one of the top roles can pay $385,000
- CFPB sues Capital One, alleges it misled consumers on savings rates
- JPMorgan Chase exec Daniel Pinto, longtime No. 2 to Jamie Dimon, will step down in June
- Stocks making the biggest moves premarket: KB Home, Signet Jewelers, Teladoc, Applied Digital & more
- Klarna scores global payment deal with Stripe to expand reach ahead of blockbuster U.S. IPO
- China's electric car boom is expected to slow down in 2025
- Investor Cliff Asness says bitcoin is a bubble unless uses besides speculation and criminality emerge
- Stocks making the biggest moves midday: Nvidia, quantum computing stocks, Moderna and more
- Why you may be paying to help make the mattress industry more eco-friendly
- Stocks making the biggest moves premarket: Abercrombie & Fitch, Pinterest, Howard Hughes Holding and more
- Analysts' top stock picks for playing China's 2025 consumer stimulus plan
- This ETF provider launches a new way to play Tesla
- Citigroup is slated to report fourth quarter earnings before the bell
- Goldman Sachs is about to report fourth-quarter earnings
- JPMorgan Chase is set to report fourth-quarter earnings – here’s what the Street expects
- 9 questions we want answered when our 3 financial names report earnings Wednesday
- Retailers hike holiday guidance, but Abercrombie's growth is slowing
- Earnings playbook: Big banks kick off the reporting season, along with a major health insurer
- Corona brewer gets slammed post-earnings, and we question whether to keep the stock
- Walgreens results top estimates as drugstore chain works to slash costs
- Delta outlook tops estimates as CEO expects 2025 to be airline's 'best financial year in our history'
- World's biggest chipmaker TSMC beats sales estimates as AI boost continues
- Lucid reports record quarterly vehicle deliveries, meets production target
- Foxconn beats estimates with record fourth-quarter revenue on AI demand
- Here is our third-quarter earnings report card for 33 stocks in the portfolio
- Rivian meets its 2024 vehicle production target after lowering projections
- Stellantis Italy output falls 37% in 2024, car production hits 68-year low